Alliancebernstein L.P. Amphastar Pharmaceuticals, Inc. Transaction History
Alliancebernstein L.P.
- $261 Billion
- Q1 2025
A detailed history of Alliancebernstein L.P. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 50,630 shares of AMPH stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,630
Previous 50,630
-0.0%
Holding current value
$1.28 Million
Previous $1.88 Million
21.93%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$150 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.24B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...